I think that is a simplistic view, skills, knowledge and unknowns probably play a role in my view #ACR17 @RheumNow https://t.co/acvvhzFKcn
— Philip Robinson (@philipcrobinson) November 8, 2017
RheumNow coverage of ACR 2017 meeting is sponsored by Horizon Pharmaceuticals.All content chosen by RheumNow Faculty https://t.co/Y6hSbkq72C
— Dr. John Cush (@RheumNow) November 8, 2017
Treatment of hyperuricemia to prevent incident dementia? Some data suggests this ¯_(ツ)_/¯ #ACR17 @RheumNow #2076 pic.twitter.com/QcRKOj0QRJ
— Dr. Paul Sufka (@psufka) November 7, 2017
“Gout pts can have septic arthritis and sickle cell pts can have gout.” Dr J Cush Keep this in your sickle cell crisis Ddx. #ACR17 @RheumNow
— Dr. Rachel Tate (@uptoTate) November 8, 2017
Possible Gout and OA connection? Human cartilage increases amount and size of MSU crystals. #ACR17 @RheumNow #2896 https://t.co/PcxEAzOcup pic.twitter.com/vQNTafMlHY
— Dr. Rachel Tate (@uptoTate) November 8, 2017
Pegloticase subanalyses show that IV Peg significantly lowers blood pressure, but only in the responders! (WATCH THE GREEN LINE) Abst#1067 @ACR17 pic.twitter.com/8KVYbMBnIX
— Dr. John Cush (@RheumNow) November 8, 2017
Low Uric acid may raise the risk of dementia. acr2017 @rheumnow#2080 pic.twitter.com/bBL1mG0Ga7
— William Shergy (@WShergy) November 8, 2017
Drink ☕️!!! Lower coffee consumption is associated with gout! #ACR17 @RheumNow #2066 pic.twitter.com/oNCSZNbNlw
— Dr. Paul Sufka (@psufka) November 7, 2017
Gout is so under treated people 😩 #ACR17 @RheumNow pic.twitter.com/Cl6EoXppxp
— Philip Robinson (@philipcrobinson) November 8, 2017
Kaplan-Meier curve; not for death… but for developing gout by serum urate concentration #ACR17 @RheumNow pic.twitter.com/c3MpMbudeJ
— Philip Robinson (@philipcrobinson) November 8, 2017
Nice data on cumulative incidence of gout by serum urate #ACR17 @RheumNow pic.twitter.com/HsDPGKLp2e
— Philip Robinson (@philipcrobinson) November 8, 2017
Allopurinol vs Febuxostat in Dementia. Yes you read that right! Jas Singh et al abs 2076 #ACR17 @RheumNow pic.twitter.com/2SPTrNKcZi
— D White (@WIRheum) November 7, 2017
More data suggesting link between low uric acid and dementia. #ACR17 @RheumNow #2080 pic.twitter.com/DWo4UeZAPn
— Dr. Paul Sufka (@psufka) November 7, 2017
Both generic and environmental factors influence the fractional excretion of uric acid #ACR17 @RheumNow #2061 pic.twitter.com/Aor1WlUEmF
— Philip Robinson (@philipcrobinson) November 7, 2017
Drink ☕️!!! Lower coffee consumption is associated with gout! #ACR17 @RheumNow #2066 pic.twitter.com/oNCSZNbNlw
— Dr. Paul Sufka (@psufka) November 7, 2017
RheumNow coverage of ACR 2017 meeting is sponsored by Horizon Pharmaceuticals.All content chosen by RheumNow Faculty https://t.co/7rwjNyBbBZ
— Dr. John Cush (@RheumNow) November 7, 2017
Dr. Philip Robinson: Fatigue and Activity
Dr. Arthur Kavanaugh: Gout, OA Posters
Dr. Ken Saag: Update on Gout Therapy
Dr. Jack Cush: When Asymptomatic Hyperuricemia Should Be Treated
Hyperuricemia is associated with more rapid knee osteoarthritis progression #ACR17 pic.twitter.com/N82t5Yn95T
— Christian Ammitzbøll (@cgytz) November 6, 2017
Hyperuricemia is strongly associated with hypertension #ACR17 pic.twitter.com/5AicrnnV65
— Christian Ammitzbøll (@cgytz) November 6, 2017
Tolerizing pegloticase regimen decreases infusion reactions in TRIPLE study #1141 #ACR17 @RheumNow @HealioRheum pic.twitter.com/yFHQMAmozK
— Cassandra Calabrese (@CCalabreseDO) November 6, 2017
Okay, I have come back to it. The data is that gout is under treated people… need to get better #ACR17 @RheumNow Abs 1121 pic.twitter.com/Aoa3ggwrP8
— Philip Robinson (@philipcrobinson) November 6, 2017
How do you approach your hyperuricemia pts? #ACR17 @RheumNow
— Dr. Rachel Tate (@DrRachelTate) November 6, 2017
#GAMECHANGERS If you have gout and typeII diabetes you have worse gout. More tophi and erosions. #acr17 @rheumnow #1118 pic.twitter.com/dIfk5DAF6u
— Janet (@Janetbirdope) November 6, 2017
#GAMECHANGER uncontrolled gout is associated with more heart failure so treat gout effectively. #acr17 @rheumnow #1119 pic.twitter.com/cBXvNfVUfs
— Janet (@Janetbirdope) November 6, 2017
Dr D Solomon #ACR17 @rheumnow YR in Review DASH diet (see photo) decrease gout risk https://t.co/rNWszhrAD9 pic.twitter.com/PKCPYTBXuv
— k dao (@KDAO2011) November 5, 2017
Do we need to change the label ‘gout’ ?!?!? Has negative stereotypes #ACR17 #1107 @RheumNow pic.twitter.com/3KtxHmBktg
— Philip Robinson (@philipcrobinson) November 6, 2017
Diuretics don’t seem to impact hugely on gout treatment objectives in this study #1129 #ACR17 @RheumNow pic.twitter.com/B7ANawXMCZ
— Philip Robinson (@philipcrobinson) November 6, 2017
Risk for CV events lower in new start probenecid (rather than allopurinol) for older >65 yo pts #ACR17 @rheumnow #159 pic.twitter.com/4E8haNTmHT
— k dao (@KDAO2011) November 6, 2017
Patients aren’t getting to urate target in gout when treated with allopurinol. Are we using enough? #166 #ACR17 @RheumNow pic.twitter.com/fyPKU9SkZz
— Philip Robinson (@philipcrobinson) November 6, 2017
Patients with gout have their XOI stopped when they present with AKI. Evidence free zone and makes gout Rx harder #1116 #ACR17 @RheumNow pic.twitter.com/HLtFRCar2u
— Philip Robinson (@philipcrobinson) November 6, 2017
Patients aren’t getting to urate target in gout when treated with allopurinol. Are we using enough? #166 #ACR17 @RheumNow pic.twitter.com/fyPKU9SkZz
— Philip Robinson (@philipcrobinson) November 6, 2017
Dr S Kim explaining to Dr Cush study on probenecid assc w/lower CV risk in elderly (eg. Cush) ACR17 @rheumnow #159 pic.twitter.com/mceU5lpysr
— k dao (@KDAO2011) November 6, 2017
Many many gout patients who are uncontrolled in the US. Need to get them on Rx #ACR17 #168 @RheumNow https://t.co/MOY3aZDwnC
— Philip Robinson (@philipcrobinson) November 6, 2017
Risk for CV events lower in new start probenecid (rather than allopurinol) for older >65 yo pts #ACR17 @rheumnow #159 pic.twitter.com/4E8haNTmHT
— k dao (@KDAO2011) November 6, 2017
Gout pts more likely to achieve sUA goal< 6 mg/dL if managed by a rheumatologist. Go team Rheum! #ACR17 #166 @rheumnow pic.twitter.com/8bo0X7bKgU
— k dao (@KDAO2011) November 6, 2017
RheumNow coverage of ACR 2017 meeting is sponsored by Horizon Pharmaceuticals.All content chosen by RheumNow Faculty https://t.co/5kftKdQhXc
— Dr. John Cush (@RheumNow) November 6, 2017
